• About Us
    • Company
    • Chairman's Message
    • Team Profile
    • Our History
    • Corporate Culture
    • Corporate Honors
  • Technology
    • Research and Development
    • Innovation Platform
    • Innovative Drugs
    • Research and Development Pipeline
  • Products
    • Digestive System
    • Cardiovascular System
    • Endocrine System
    • Nervous System
    • Inflammation
    • Respiratory System
  • News
    • Company News
    • Media Coverage
  • Investor Relations
    • Announcements and Circulars
    • Financial Reports
    • Prospectus
    • Corporate Governance
    • Contact IR
  • Careers
    • Talent Development
    • Recruitment Position
  • Contact Us
    • Contact Us
    • Product Consultation
  • 简 繁 EN
  • 中文
  • 繁体
  • EN
  • About Us
  • Company
  • Chairman's Message
  • Team Profile
  • Our History
  • Corporate Culture
  • Corporate Honors
  • Technology
  • Research and Development
  • Innovation Platform
  • Innovative Drugs
  • Research and Development Pipeline
  • Products
  • Digestive System
  • Cardiovascular System
  • Endocrine System
  • Nervous System
  • Inflammation
  • Respiratory System
  • News
  • Company News
  • Media Coverage
  • Investor Relations
  • Announcements and Circulars
  • Financial Reports
  • Prospectus
  • Corporate Governance
  • Contact IR
  • Careers
  • Talent Development
  • Recruitment Position
  • Contact Us
  • Contact Us
  • Product Consultation
Corporate Governance
  1. Home
  2. Investor Relations
Announcements and Circulars Financial Reports Prospectus Corporate Governance Contact IR
Corporate Governance
Articles of Association Rules of Procedure for Shareholders' Meeting Rules of Procedure for Meeting of the Board of Directors Terms of Reference of the Nomination Committee of the Board of Directors of the Company
Board of Directors
Committees

Audit Committee

Pu Meiting (Chairman)


Lin Bin


Wang Shanshan


Nomination Committee

Wang Shanshan(Chairman)


Kang Xinshan


Pu Meiting


Remuneration and Appraisal Committee

Wang Shanshan(Chairman)


Kang Xinshan


Pu Meiting


Strategy Committee

Kang Xinshan (Chairman)


Feng Yan


Lin Bin


About Us
Technology
Products
News
Investor Relations
Careers
Contact Us

Fujian Haixi Pharmaceutical Co., Ltd. Fujian ICP Record No. 12015727 Internet Drug Information Service Qualification Certificate No.: (Min)-Non-operating-2023-0063

Some texts and images on this website are sourced from the Internet for sharing and learning purposes only. If any content infringes your rights and interests, please notify us promptly, and we will handle or remove the relevant materials without delay.